Media Hub

Jun 2017

Blood test targets advanced prostate cancer drug treatment

Prostate cancer is the most common cancer amongst men in the UK, with over 46,000 diagnosed with the disease each year. A blood test has been developed to identify which advanced patients would benefit from a new drug treatment. The test, which identifies cancer DNA in the blood, enables doctors to check whether precision drugs…

Read More

May 2017

New prostate cancer test could reduce biopsies by 50 per cent

The current method of testing for prostate cancer is fairly unreliable. It frequently produces inaccurate results that can result in patients undergoing unnecessary surgery, putting them at risk of erectile dysfunction or urinary incontinence. However, according to researchers, a new blood test, known as IsoPSA, has been shown to detect the cancer more precisely. The new…

Read More